Michael P Murtaugh

Author:

Michael P. Murtaugh

ISBN #:

0824794354

US Patent:

7611717, Nov 3, 2009

Filed:

Jun 17, 2005

Appl. No.:

11/155830

Inventors:

Michael P. Murtaugh - Shoreview MN, US
Craig R. Johnson - Lakeville MN, US

Assignee:

Regents of the University of Minnesota - Saint Paul MN

International Classification:

A61K 39/12

US Classification:

4242041, 435 6

Abstract:

This document provides methods and materials related to assessing organisms for the presence or absence of anti-virus antibodies. For example, this document provides methods and materials that can be used to determine whether or not an organism (e. g. , a member of a swine species such as a pig) contains anti-PRRS virus antibodies. In other embodiments, this document provides methods and materials that can be used to determine if a particular organism received a vaccine version of a virus, was infected with a naturally-occurring version of the virus, or is naive with respect to the virus.

US Patent:

8399187, Mar 19, 2013

Filed:

Oct 8, 2009

Appl. No.:

12/576067

Inventors:

Michael P. Murtaugh - Shoreview MN, US
Craig R. Johnson - Eagan MN, US

Assignee:

Regents of the University of Minnesota - St. Paul MN

International Classification:

C12Q 1/70

US Classification:

435 5, 435 71

Abstract:

This document provides methods and materials related to assessing organisms for the presence or absence of anti-virus antibodies. For example, this document provides methods and materials that can be used to determine whether or not an organism (e. g. , a member of a swine species such as a pig) contains anti-PRRS virus antibodies. In other embodiments, this document provides methods and materials that can be used to determine if a particular organism received a vaccine version of a virus, was infected with a naturally-occurring version of the virus, or is naïve with respect to the virus.

US Patent:

20080268426, Oct 30, 2008

Filed:

Jun 12, 2008

Appl. No.:

12/138166

Inventors:

Michael P. Murtaugh - Shoreview MN, US
Craig R. Johnson - Eagan MN, US

Assignee:

REGENTS OF THE UNIVERSITY OF MINNESOTA - Saint Paul MN

International Classification:

C12Q 1/70

US Classification:

435 5

Abstract:

This document provides methods and materials related to assessing organisms for the presence or absence of anti-virus antibodies. For example, this document provides methods and materials that can be used to determine whether or not an organism (e.g., a member of a swine species such as a pig) contains anti-PRRS virus antibodies. In other embodiments, this document provides methods and materials that can be used to determine if a particular organism received a vaccine version of a virus, was infected with a naturally-occurring version of the virus, or is naïve with respect to the virus.

US Patent:

55543715, Sep 10, 1996

Filed:

Apr 14, 1994

Appl. No.:

8/227478

Inventors:

Anthony C. Caputa - Nanuet NY
Russell F. Bey - Arden Hills MN
Michael P. Murtaugh - Roseville MN

Assignee:

Regents of the University of Minnesota - Minneapolis MN

International Classification:

A61K 3900
A61K 3902
C12P 2100
C07K 1600

US Classification:

4242341

Abstract:

A highly-antigenic, recombinant polypeptide of a molecular weight of about 110-kD by SDS-PAGE is disclosed, which is derived by transforming E. coli with a 7. 1 kB DNA fragment from EcoR1-digested B. burgdorferi DNA, followed by identification of cloned transformants expressing polypeptides which bind to anti-B. burgdorferi antibodies.

US Patent:

59986018, Dec 7, 1999

Filed:

Feb 13, 1997

Appl. No.:

8/799464

Inventors:

Michael P. Murtaugh - Roseville MN
Margaret R. Elam - Minneapolis MN
Laura T. Kakach - Hopkins MN

Assignee:

Regents of The University of Minnesota - Minneapolis MN

International Classification:

C07H 2104
A61K 3902
A61K 3912

US Classification:

536 2372

Abstract:

A nucleotide sequence is provided for the VR-2332 virus, which is capable of causing Porcine Reproductive and Respiratory Syndrome. The nucleotide sequence includes protein coding regions that are inserted into recombinant vectors for the host expression of viral proteins according to a variety of vaccination techniques. Diagnostic assays utilize fragmentary sequences or oligonucleotides to selectively identify the VR-2332 nucleic acids by hybridization or PCR amplification reactions that distinguish VR-2332 nucleotide sequences from other PRRS-causative viruses which are immunologically distinct from VR-2332.